GSK Investigational Site

Harvey, Illinois 60426

1 studies enrolling now · 3 studies all time

What they study most

Breast Neoplasms, Lung Cancer, Non-Small Cell, Neoplasms, Ovarian Neoplasms

Studies at this site

• A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study — Recruiting now
• Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants — Completed
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early